28
Participants
Start Date
October 31, 2005
Primary Completion Date
May 31, 2006
Study Completion Date
June 30, 2006
Temperature controlled Laminar Airflow (Protexo)
The intervention is designed to reduce the allergen load in the patients breathing zone by vertically displacing the allergens, originating from the bed and the ambient room environment, with a temperature controlled laminar airflow (TLA) during night sleep. The airflow is filtered through a high efficiency particulate air filter(HEPA), slightly cooled and ''showered'' over the subject. Due to the higher density, the cooled air descends slowly, and displaces the allergens from the breathing zone.
Placebo TLA
TLA treatment with disabled filtration function
University Hospital, Linkoeping, Linköping
Karolinska University Hospital, Stockholm
Karolinska University Hospital
OTHER
University Hospital, Linkoeping
OTHER
Quintiles, Inc.
INDUSTRY
Airsonett AB
INDUSTRY